FR3113452A1 - Mosquito Repellent Scent - Google Patents
Mosquito Repellent Scent Download PDFInfo
- Publication number
- FR3113452A1 FR3113452A1 FR2006515A FR2006515A FR3113452A1 FR 3113452 A1 FR3113452 A1 FR 3113452A1 FR 2006515 A FR2006515 A FR 2006515A FR 2006515 A FR2006515 A FR 2006515A FR 3113452 A1 FR3113452 A1 FR 3113452A1
- Authority
- FR
- France
- Prior art keywords
- composition according
- chosen
- repellent
- glycerin
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000077 insect repellent Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 239000005871 repellent Substances 0.000 claims abstract description 11
- 230000002940 repellent Effects 0.000 claims abstract description 11
- 235000011187 glycerol Nutrition 0.000 claims abstract description 10
- 239000002304 perfume Substances 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 150000003869 acetamides Chemical class 0.000 claims abstract description 5
- 150000001733 carboxylic acid esters Chemical class 0.000 claims abstract description 5
- 244000144927 Aloe barbadensis Species 0.000 claims description 12
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 12
- 235000011399 aloe vera Nutrition 0.000 claims description 12
- VZRKEAFHFMSHCD-UHFFFAOYSA-N Ethyl 3-(N-butylacetamido)propionate Chemical compound CCCCN(C(C)=O)CCC(=O)OCC VZRKEAFHFMSHCD-UHFFFAOYSA-N 0.000 claims description 11
- 239000010658 moringa oil Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 4
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 2
- 244000060011 Cocos nucifera Species 0.000 claims description 2
- 244000288157 Passiflora edulis Species 0.000 claims description 2
- 235000000370 Passiflora edulis Nutrition 0.000 claims description 2
- 229940068517 fruit extracts Drugs 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 241000220215 Moringa Species 0.000 description 6
- 235000011347 Moringa oleifera Nutrition 0.000 description 6
- 241000255925 Diptera Species 0.000 description 5
- VWTINHYPRWEBQY-UHFFFAOYSA-N denatonium Chemical compound [O-]C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C VWTINHYPRWEBQY-UHFFFAOYSA-N 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- VSMOENVRRABVKN-UHFFFAOYSA-N oct-1-en-3-ol Chemical compound CCCCCC(O)C=C VSMOENVRRABVKN-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 3
- 239000002917 insecticide Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000468081 Citrus bergamia Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960001610 denatonium benzoate Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
L’invention concerne une composition comprenant un répulsif choisi dans la famille des esters carboxyliques et des acétamides et un parfum dissous dans un solvant hydroalcoolique comprenant de la glycérine.The invention relates to a composition comprising a repellent chosen from the family of carboxylic esters and acetamides and a perfume dissolved in a hydroalcoholic solvent comprising glycerin.
Description
Les moustiques représentent une menace pour la santé humaine car ils transmettent des parasites, des nématodes et des virus. C'est pourquoi différentes méthodes visent à contrôler les populations de moustiques et à empêcher leur contact avec les Hommes, les deux principales étant l’utilisation de répulsifs qui éloignent les moustiques et/ou l’utilisation d’insecticides qui les tuent.Mosquitoes pose a threat to human health as they transmit parasites, nematodes and viruses. This is why different methods aim to control mosquito populations and prevent their contact with humans, the two main ones being the use of repellents that keep mosquitoes away and/or the use of insecticides that kill them.
Cependant la résistance des moustiques aux insecticides pose problème et les insecticides sont souvent eux-mêmes un danger pour la santé humaine. Les répulsifs sont donc à privilégier mais leur efficacité peut être limitée par le fait que ces insectes sont par ailleurs attirés par des molécules produites par le corps humain ou par des bactéries qui dégradent des composants de la sueur. Par exemple, l'acide lactique et le oct-1-én-3-ol sont deux molécules qui attirent les moustiques.However, mosquito resistance to insecticides is a problem and insecticides are often themselves a danger to human health. Repellents are therefore to be preferred, but their effectiveness may be limited by the fact that these insects are also attracted by molecules produced by the human body or by bacteria which degrade components of sweat. For example, lactic acid and oct-1-en-3-ol are two molecules that attract mosquitoes.
La présente invention permet de résoudre les problèmes cités ci-dessus en ce qu‘elle consiste en une composition parfumée qui comprend en outre un répulsif et au moins un parfum qui permet de masquer l’odeur des molécules produites par le corps humain et ainsi d’améliorer significativement l’effet du répulsif.The present invention makes it possible to solve the problems mentioned above in that it consists of a perfumed composition which further comprises a repellent and at least one perfume which makes it possible to mask the smell of the molecules produced by the human body and thus to significantly improve the effect of the repellent.
La présente invention permet en outre de réduire les problèmes de tolérance cutanée qui peuvent apparaitre lors de l’utilisation répétée de répulsif. De plus l’efficacité améliorée de la composition selon l’invention permet d’espacer les applications cutanées.The present invention also makes it possible to reduce the problems of skin tolerance which may appear during the repeated use of repellents. In addition, the improved effectiveness of the composition according to the invention makes it possible to space out the cutaneous applications.
Dans un mode de réalisation, la présence d’huile de moringa dans la composition permet également de limiter les odeurs corporelles du fait de ses propriétés antibactériennes et antioxydantes puissantes.In one embodiment, the presence of moringa oil in the composition also makes it possible to limit body odor due to its powerful antibacterial and antioxidant properties.
Elle permet en outre d’améliorer la tolérance cutanée même en cas d’utilisation répétée et sur des peaux dites fragiles.It also improves skin tolerance even in the event of repeated use and on so-called fragile skin.
L’invention concerne une composition comprenant un répulsif choisi dans la famille des esters carboxyliques et des acétamides et un parfum dissous dans un solvant hydroalcoolique comprenant de la glycérine.The invention relates to a composition comprising a repellent chosen from the family of carboxylic esters and acetamides and a perfume dissolved in a hydroalcoholic solvent comprising glycerin.
Dans un mode de réalisation, elle comprend en outre de l’huile de moringa.In one embodiment, it further comprises moringa oil.
Dans un mode de réalisation, elle comprend en outre un extrait d’aloe vera.In one embodiment, it further comprises an extract of aloe vera.
Dans un mode de réalisation, le répulsif choisi dans la famille des esters carboxyliques et des acétamides est le butylacétylaminopropanoate d'éthyle ou butylacétylaminopropionate d'éthyle (CAS n°52304-36-6).In one embodiment, the repellent chosen from the family of carboxylic esters and acetamides is ethyl butylacetylaminopropanoate or ethyl butylacetylaminopropionate (CAS No. 52304-36-6).
Dans un mode de réalisation, la composition comprend de 15 à 30 % et de préférence 20 % de butylacétylaminopropanoate d'éthyle.In one embodiment, the composition comprises from 15 to 30% and preferably 20% of ethyl butylacetylaminopropanoate.
Dans un mode de réalisation, le parfum est choisi dans les eaux de Cologne et/ou les extraits de noix de coco et/ou les extraits de fruits de la passion.In one embodiment, the fragrance is selected from colognes and/or coconut extracts and/or passion fruit extracts.
Les parfums sont choisis de manière à masquer les odeurs corporelles qui attirent les insectes et plus particulièrement l'acide lactique, le oct-1-én-3-ol, l’acide urique ou encore l'ammoniaque.The perfumes are chosen in such a way as to mask body odors that attract insects and more particularly lactic acid, oct-1-en-3-ol, uric acid or even ammonia.
On entend par solvant hydroalcoolique un mélange d’éthanol et d’eau comprenant de 50 à 95 % d’éthanol.Hydroalcoholic solvent means a mixture of ethanol and water comprising 50 to 95% ethanol.
Dans un mode de réalisation, le solvant hydroalcoolique comprend de 60 à 70 % d’éthanol.In one embodiment, the hydroalcoholic solvent comprises 60 to 70% ethanol.
Le solvant hydroalcoolique comprend en outre de la glycérine pour son pouvoir hydratant, solvant et lubrifiant. On entend par glycérine, le glycérol (CAS n°56-81-5), de préférence d’origine végétale.The hydroalcoholic solvent also includes glycerin for its moisturizing, solvent and lubricating power. By glycerin is meant glycerol (CAS No. 56-81-5), preferably of vegetable origin.
Dans un mode de réalisation, la composition comprend moins de 1 % de glycérine et de préférence entre 0,1 et 0,5 % de glycérine.In one embodiment, the composition comprises less than 1% glycerin and preferably between 0.1 and 0.5% glycerin.
L’huile de moringa est obtenue à partir des graines de l’arbre de moringa.Moringa oil is obtained from the seeds of the moringa tree.
L’huile de moringa est extraite des graines de moringa qui sont composées de 30% d’huile.Moringa oil is extracted from moringa seeds which are composed of 30% oil.
Le moringa est un arbre tropical à croissance rapide originaire des régions du nord de l’Inde qui pousse également en Afrique et en Amérique du Sud, notamment au Brésil.Moringa is a fast-growing tropical tree native to the northern regions of India that also grows in Africa and South America, including Brazil.
Cette huile est un antioxydant naturel puissant, réputé pour ses propriétés antibactériennes, antimicrobiennes et anti-inflammatoires. L’huile de moringa est très riche en vitamines A, B et C.This oil is a powerful natural antioxidant, renowned for its antibacterial, antimicrobial and anti-inflammatory properties. Moringa oil is very rich in vitamins A, B and C.
L’huile de moringa contient plus de 12% d’acides gras saturés et 80% d’acides gras insaturés. Cette huile est très riche en acide oléique, un acide gras monoinsaturé de l’oméga 9.Moringa oil contains more than 12% saturated fatty acids and 80% unsaturated fatty acids. This oil is very rich in oleic acid, a monounsaturated fatty acid of omega 9.
Dans un mode de réalisation, la composition comprend moins de 5 % d’huile de moringa et de préférence entre 0,5 et 2 % d’huile de moringa.In one embodiment, the composition comprises less than 5% moringa oil and preferably between 0.5 and 2% moringa oil.
Aloe barbadensis (aloe vera, Aloe vulgaris, Aloe) est originaire d'Égypte ou du Moyen-Orient, mais la plante est naturalisée et cultivée sous les tropiques et dans les régions chaudes du globe en Afrique, en Inde en Asie, dans les Caraïbes, en Amérique du Sud, au Mexique, dans le sud des États-Unis.Aloe barbadensis (aloe vera, Aloe vulgaris, Aloe) is native to Egypt or the Middle East, but the plant is naturalized and cultivated in the tropics and in warm regions of the globe in Africa, India, Asia, the Caribbean , South America, Mexico, southern United States.
Le latex jaune tiré de la couche externe des feuilles et le gel d'aloe vera clair et mucilagineux, extrait de l'intérieur des feuilles d'aloe vera sont utilisés.The yellow latex taken from the outer layer of the leaves and the clear, mucilaginous aloe vera gel extracted from the inside of the aloe vera leaves are used.
Outre ses propriétés hydratantes, l’aloe-vera est une source de polyphénols et de phytostérols qui sont des acides gras ayant des propriétés antioxydantes.Besides its moisturizing properties, aloe vera is a source of polyphenols and phytosterols which are fatty acids with antioxidant properties.
Dans un mode de réalisation, la composition comprend moins de 5 % d’aloe vera et de préférence entre 0,1 et 0,5% d’aloe vera.In one embodiment, the composition comprises less than 5% aloe vera and preferably between 0.1 and 0.5% aloe vera.
La composition selon l’invention comprend, en outre, d’autres parfums comme la bergamote.The composition according to the invention also comprises other fragrances such as bergamot.
Elle comprend en outre des répulsifs pour prévenir l’ingestion comme le benzoate de dénatonium, commercialisé sous la marque Bitrex.It also includes repellents to prevent ingestion such as denatonium benzoate, marketed under the Bitrex brand.
Exemple 1 compositions selon l’invention.
Example 1 compositions according to the invention.
Composition 1
Composition 2
Composition 3
Exemple 2Example 2
Etude de la compatibilité cutanée via la détermination du potentiel irritant primaire après application unique sous patch-test.Study of skin compatibility by determining the primary irritant potential after a single application under a patch test.
L’étude a été réalisée en simple aveugle, les consentements éclairés des volontaires ont été recueillis et les critères d’inclusion ont été les suivants, âge 18-70 ans, âge moyen 54 ± 4 ans.The study was carried out single-blind, the informed consents of the volunteers were collected and the inclusion criteria were as follows, age 18-70 years, average age 54 ± 4 years.
Des patchs semi-occlusifs ont été appliqués pendant 48 heures, lesdits patchs comprenant 40 µl ce composition selon l’exemple 2.Semi-occlusive patches were applied for 48 hours, said patches comprising 40 μl of this composition according to Example 2.
Les examens macroscopiques cutanés ont été réalisés dans les mêmes conditions, en particulier au niveau de l’éclairage (lumière standardisée), 15-30 minutes après le retrait des patch-tests et 24 heures plus tard. Dans le cas d’une réaction cutanée > 1 à la lecture à 24 heures, le volontaire devait revenir au centre, des lectures étant effectuées jusqu’à réversibilité complète des réactions cutanées.The macroscopic skin examinations were carried out under the same conditions, in particular at the level of lighting (standardized light), 15-30 minutes after removal of the patch-tests and 24 hours later. In the event of a skin reaction > 1 on the 24-hour reading, the volunteer was to return to the centre, with readings taken until the skin reactions were completely reversible.
L’étude a permis de conclure que la composition testée est non-irritante.The study concluded that the composition tested is non-irritating.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2006515A FR3113452B1 (en) | 2020-06-22 | 2020-06-22 | Mosquito repellent fragrance |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2006515 | 2020-06-22 | ||
FR2006515A FR3113452B1 (en) | 2020-06-22 | 2020-06-22 | Mosquito repellent fragrance |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3113452A1 true FR3113452A1 (en) | 2022-02-25 |
FR3113452B1 FR3113452B1 (en) | 2024-01-19 |
Family
ID=72644399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR2006515A Active FR3113452B1 (en) | 2020-06-22 | 2020-06-22 | Mosquito repellent fragrance |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3113452B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3147948A1 (en) * | 2023-04-20 | 2024-10-25 | Laboratoire Astelia | Soothing after injection, high tolerance without any contraindications |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10349666A1 (en) * | 2003-10-24 | 2005-05-25 | Beiersdorf Ag | Aqueous or aqueous-alcoholic insect repellent cosmetic formulation, useful on skin and/or hair, contains combination of repellent(s) and Aloe vera extract, Hammamelis extract and/or extracts of oyster and sea silt |
EP1745772A2 (en) * | 2005-07-20 | 2007-01-24 | Beiersdorf AG | Insect repellents with improved activity |
EP1997378A2 (en) * | 2007-05-31 | 2008-12-03 | Beiersdorf AG | Wasp repellents |
WO2018017919A2 (en) * | 2016-07-21 | 2018-01-25 | Sanit Technologies Llc | Mosquito repellant |
CN110420150A (en) * | 2019-09-16 | 2019-11-08 | 深圳市悦青春健康科技有限公司 | A kind of anti-aging skin care product composition containing Moringa seed extract |
-
2020
- 2020-06-22 FR FR2006515A patent/FR3113452B1/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10349666A1 (en) * | 2003-10-24 | 2005-05-25 | Beiersdorf Ag | Aqueous or aqueous-alcoholic insect repellent cosmetic formulation, useful on skin and/or hair, contains combination of repellent(s) and Aloe vera extract, Hammamelis extract and/or extracts of oyster and sea silt |
EP1745772A2 (en) * | 2005-07-20 | 2007-01-24 | Beiersdorf AG | Insect repellents with improved activity |
EP2119432A2 (en) * | 2005-07-20 | 2009-11-18 | Beiesrdorf Ag | Insect repellents with improved activity |
EP1997378A2 (en) * | 2007-05-31 | 2008-12-03 | Beiersdorf AG | Wasp repellents |
WO2018017919A2 (en) * | 2016-07-21 | 2018-01-25 | Sanit Technologies Llc | Mosquito repellant |
CN110420150A (en) * | 2019-09-16 | 2019-11-08 | 深圳市悦青春健康科技有限公司 | A kind of anti-aging skin care product composition containing Moringa seed extract |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3147948A1 (en) * | 2023-04-20 | 2024-10-25 | Laboratoire Astelia | Soothing after injection, high tolerance without any contraindications |
Also Published As
Publication number | Publication date |
---|---|
FR3113452B1 (en) | 2024-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITPI20110101A1 (en) | HELICHRYSUM EXTRACT IN JOJOBA OIL AND COMPOSITIONS BASED ON SUCH EXTRACT, IN PARTICULAR, TO TREAT SKIN CONDITIONS | |
US9198435B2 (en) | Natural pesticide composition and method of producing | |
Torres et al. | Neutralizing effects of Nectandra angustifolia extracts against Bothrops neuwiedi snake venom | |
CN112370379A (en) | Plant essential oil spray for repelling mosquitoes, relieving itching and inhibiting bacteria and application | |
EP2405760A1 (en) | Extract of euodia suaveolens scheff, repellent compositions, and use thereof | |
US20220167631A1 (en) | Insect repelling compositions and methods of manufacture thereof | |
FR3113452A1 (en) | Mosquito Repellent Scent | |
AP707A (en) | Aromatic composition based on olibanum combined with a synergic agent (e.g. Eucalyptol, borneol, zinc salt, copper salt) and use thereof. | |
KR101174042B1 (en) | Mixture extract having insecticidal and repellent effects and products using the same | |
FR2759546A1 (en) | Use of citronella components as insecticides | |
FR2622103A1 (en) | Novel insect-repellent dermatological suntan compositions | |
Ganiyat et al. | Chemical composition, toxicity, antimicrobial and antioxidant activities of leaf and stem essential oils of Dieffenbachia picta (Araceae) | |
DE202006012266U1 (en) | Natural healing and care oil, useful e.g. for treating wounds, joint pain and rheumatism, comprises extra virgin olive oil and tincture of propolis | |
FR2837702A1 (en) | Cosmetic composition useful as a skin antiaging and night care product comprises extracts of Mirabilis jalapa, Laminaria cloustoni and Citrus reticulata | |
EP4096638A1 (en) | Protecting skin from allergens | |
EP3143876A1 (en) | Insecticidal composition containing geraniol and/or citronellal | |
JP2010527349A (en) | Mosquito repellent | |
JP2003160502A (en) | Production method of active fraction obtained from pyroligneous acid and utilization thereof | |
Cutovic et al. | Antioxidant activity of Paeonia tenuifolia L. petal extract-loaded liposomes | |
WO2005034898A1 (en) | Dermo-cosmetic composition for pets | |
ES2304323B1 (en) | EXTRACT OF THE COUROUPITA GUIANENSIS SHEETS, PROCEDURE OF OBTAINING AND ITS COSMETIC USE AS AN ANTIOXIDANT / ANTIRRADICALARY / UV FILTER. | |
FR2906441A1 (en) | Lipophilic composition of natural active ingredient derived from herbal material useful as insect repellent, comprises synergistic mixture of terpenic alcohol, essential oil and non-active oil | |
WO2016097496A1 (en) | Use of evodone derivatives as repellent, novel evodone derivatives and synthesis process | |
Sharifi | Fractionations and analysis of trunk exudates from Pistacia genus in relation to antimicrobial activity | |
Iftikhar et al. | Propolis an antibacterial agent against clinical isolates of wound infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20220225 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |